Paraneoplastic polymyositis (Q44383): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||
| Property / Linked ICD 10 | |||
| Property / Linked ICD 10: M33.2 / rank | |||
Normal rank | |||
Latest revision as of 11:49, 13 August 2026
Paraneoplastic is a rare cancer associated entity. It presents sub-, or acutely with proximal weakness, often including the neck flexors, dysphagia, rarely the respiratory muscles and the heart are involved. Sometimes muscle pain or myalgia occur. Myopathology shows a targeted, cell-mediated lymphocyte toxicity against muscle fibres in focal areas of inflammation within perimysial connective tissue and surrounding blood vessels. Muscle fibres may be destroyed by cytotoxic T cells. Non-Hodgkin’s lymphoma, lung, and bladder carcinoma are the most frequently observed associated cancer types.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 4A41.11 |
||
| English | Paraneoplastic polymyositis |
Paraneoplastic is a rare cancer associated entity. It presents sub-, or acutely with proximal weakness, often including the neck flexors, dysphagia, rarely the respiratory muscles and the heart are involved. Sometimes muscle pain or myalgia occur. Myopathology shows a targeted, cell-mediated lymphocyte toxicity against muscle fibres in focal areas of inflammation within perimysial connective tissue and surrounding blood vessels. Muscle fibres may be destroyed by cytotoxic T cells. Non-Hodgkin’s lymphoma, lung, and bladder carcinoma are the most frequently observed associated cancer types. |
Statements
CID11:4A41.11
0 references
dki-india-4A41.11
0 references
Concluído
0 references
13 August 2026
0 references
